# Cardio Diagnostics Holdings Inc. (CDIO)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $3M  
**Price:** $1.93 (-0.52%)

> Cardio Diagnostics Holdings Inc. is a biotechnology company in the healthcare sector that develops and commercializes epigenetics-based clinical tests for cardiovascular disease prevention, early detection, and management. Its primary offerings include Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment blood test targeting events like heart attacks; PrecisionCHD, an integrated epigenetic-genetic blood test for detecting coronary heart disease; and Actionable Clinical Intelligence, a platform delivering epigenetic and genetic insights to clinicians for improved chronic care management. The company also provides CardioInnovate360, a research-use-only solution supporting biopharmaceutical discovery and validation for cardiovascular diseases, and HeartRisk, a SaaS platform offering real-time cardiovascular risk intelligence from aggregated clinical data. Cardio Diagnostics Holdings Inc. serves telemedicine providers, concierge practices, longevity clinics, risk-bearing provider organizations, employer organizations, and correctional facilities, leveraging AI-driven multi-omics technology for personalized molecular insights beyond traditional risk factors. Founded in 2017 and headquartered in Chicago, Illinois, it focuses on making cardiovascular care more accessible and precise.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $14,825 | — | -$6M | -$6M | — |
| 2024 | $34,890 | — | -$8M | -$8M | — |
| 2023 | $17,065 | — | -$7M | -$8M | — |
| 2022 | $950 | — | -$5M | -$5M | — |
| 2021 | $901 | — | -$620,448 | -$620,448 | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $8M | $793,061 | $7M | — | — |
| 2024 | $11M | $1M | $10M | — | — |
| 2023 | $4M | $2M | $3M | — | — |
| 2022 | $6M | $2M | $4M | — | — |
| 2021 | $1M | $33,885 | $1M | — | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | -$6M | $187,317 | -$6M |
| 2024 | -$5M | $214,765 | -$5M |
| 2023 | -$6M | $575,663 | -$6M |
| 2022 | -$5M | — | — |
| 2021 | -$585,291 | — | — |

Source: [CompaniesByCap](https://companiesbycap.com/company/CDIO)